FKBPs与神经退行性疾病
被引量:2
FK506-BINDING PROTEINS AND NEURODEGENERATIVE DISEASES
出处
《药学学报》
CAS
CSCD
北大核心
2002年第9期743-748,共6页
Acta Pharmaceutica Sinica
基金
国家重点基础研究规划项目 (G19980 5110 7)
国家自然科学基金海外青年学者合作研究基金 ( 3992 80 11)
国家自然科学基金项目 ( 30 0 0 0 2 15)
参考文献33
-
1Sharkey J, Butcher SP. Immunophilins mediate the neuroprotective effects of FK506 in focal celebral ischaemia [J]. Nature, 1994,371(6495):336-339.
-
2Takahashi N, Hayano T, Suzuki M. Peptidyl-propyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin [J]. Nature, 1989,337(6206):473-475.
-
3Harding MW, Galat A, Uehling DE, et al. A receptor for the immuno-suppressant FK506 is a cis-trans peptidyl-prolyl isomerase [J]. Nature, 1989,341(6244):761-763.
-
4Rahfeld JU, Rucknagel KP, Schelbert B, et al. Confirmation of the existence of a third family among peptidyl-prolyl cis/trans isomerases. Amino acid sequence and recombinant production of parvulin [J]. FEBS Lett, 1994,352(2):180-184.
-
5Van Duyne GD, Standaert RF, Karplus PA, et al. Atomic structures of the human immunophilin FKBP-12 complexes with FK506 and rapamycin [J]. J Mol Biol, 1993,229(1):105-124.
-
6Pfluegl G, Kallen J, Schirmer T, et al. X-ray structure of a decameric cyclophilin-cyclosporin crystal complex [J]. Nature, 1993,361(6407):91-94.
-
7Friedman J, Weissman I. Two cytoplastic candidates for immunophilin action are revealed by affinity for a new cyclophilin: one in the presence and one in the absence of CsA [J]. Cell, 1991,66(4):799-806.
-
8Liu J. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes [J]. Cell, 1991,66(4):807-815.
-
9Freman DA, Klee CB, Bierer BE, et al. Calcineurin phosphatase activity in T lymphocytes is inhibited by FK506 and cyclosporin A [J]. Proc Natl Acad Sci USA, 1992,89(9):3686-3690.
-
10Bierer BE, Mattila PS, Standaert RF, et al. Two distinct signal transmission pathways are inhibited in T-lymphocytes by complexes formed between an immunophilin and either FK506 or rapamycin [J]. Proc Natl Acad Sci USA, 1990,87(23):9231-9235.
同被引文献38
-
1吕德成,袁先厚,张卫国,傅重洋.利用神经再生室观察FK506促进神经再生的实验研究[J].中华医学杂志,2005,85(28):1978-1981. 被引量:9
-
2Fischer G, Bang H. Mech C. Determination of enzymatic catalysis for the cis-trans-isomerization of peptide binding in proline-containing peptides [J]. Biomed Biochim Acta. 1984.43(10) :1101-11.
-
3Takahashi N. Hayano T. Suzuki M. Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin [J].Nature. 1989,Feb 2;337(6206) :473-5.
-
4Harrison RK, Stein RL. Substrate specificities of the peptidyl prolyl cis-trans isomerase activeities of cyclophilin and FK-506 binding protein:evidence for the existence of a family of distinct enzymes[J]. Biochemistry. 1990,Apr 24;29(16): 3813-6.
-
5Galat A. Lane WS, Standaert RF et al. A rapamycin-selective 25-kDa immunophilin [J]. Biochemistry. 1992, Mar 3 ; 31 (8):2427-34.
-
6Tropschug M, Wachter E, Mayer S et al. Isolation and sequence of an FK506-binding protein from N. crassa which catalyses protein folding[J]. Nature. 1990,Aug 16;346(6285) :674-7.
-
7Harding MW, Galat A, Uehling DE,Schreiber SL. A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase[J]. Nature. 1989.Oct 26;341(6244):758-60.
-
8Pahl A, Keller U. FK-506-binding proteins from streptomycetes producing immunosuppressive macrolactones of the FK-506 type [J]. J Bacteriol. 1992,Sep;174(18):5888-94.
-
9Riviere S, Menez A, Galat A. On the localization of FKBP25 in T-lymphocytes[J]. FEBS Lett. 1993, Jan 11 ;315(3) :247-51.
-
10Jin YJ, Burakoff SJ. The 25-kDa FKS06-binding protein is localized in the nucleus and associates with casein kinase Ⅱ and nucleolin[J]. Proc Natl Acad Sci U S A. 1993,Aug 15;90(16):7769-73.
引证文献2
-
1陈鹏,陈崇宏,程元荣.FKBPs的研究进展[J].海峡药学,2004,16(3):6-10. 被引量:2
-
2张延明,肖军海,赵云,韩丹,王大江,杨静,方伯言.新型FKBPs配体HD5-6对SAMP8小鼠的抗老化研究[J].中风与神经疾病杂志,2014,31(1):4-8. 被引量:1
二级引证文献3
-
1孙丽娟,黄捷.含氮大环内酯类免疫抑制剂的生物合成[J].海峡药学,2007,19(6):11-15. 被引量:2
-
2张玲玲,邱彬,杨志伟,雍伟东.Fkbp51与应激相关疾病的研究进展[J].中国比较医学杂志,2016,26(11):90-94. 被引量:1
-
3姜丹,王巍,毕倩楠,苏丹丹.一种1,4-噻嗪酰胺类FKBPs配体的波谱学数据解析[J].波谱学杂志,2018,35(2):204-214.
-
1闫欣.多发性硬化的治疗策略[J].中国社区医师,2013(20):8-9.
-
2富文俊,曹国平,富丽俊.慢性应激神经可塑性调控机制研究进展及逍遥散的调控作用探讨[J].中华中医药杂志,2015,30(12):4384-4387. 被引量:6
-
3何星瑶,容国安,廖明珍.小儿脑性瘫痪的病因研究近况[J].广西中医学院学报,2011,14(4):75-76. 被引量:5
-
4杨斯柳,顾卫红.神经变性病与抗氧化剂[J].中日友好医院学报,2007,21(4):235-237.
-
5侯文敏,杨海河,吴惠兰,张丽凤.258例小儿脑性瘫痪临床分析[J].脑与神经疾病杂志,2001,9(5):295-295.
-
6王常欣,周广福,亓法英,王玲玲.肌萎缩侧索硬化180例临床分析[J].临床军医杂志,2002,30(6):45-46. 被引量:4
-
7程柱生.常饮绿茶有助于预防老年痴呆症[J].现代养生,2010(9):44-44.
-
8梁新生,朱晓省.特发性震颤15例临床分析[J].中国基层医药,2002,9(5):444-444.
-
9You-E YAN,Hui WANG,Ming FAN.Molecular chaperones and neurodegenerative diseases[J].Neuroscience Bulletin,2006,22(2):118-123. 被引量:1
-
10高国祥,王静冉.齐拉西酮治疗老年痴呆患者精神行为异常的临床疗效及对糖脂代谢的影响[J].实用临床医药杂志,2015,19(9):140-142. 被引量:10